Diltiazem Hydrochloride

Diltiazem Hydrochloride | Sciegen Pharmaceuticals Intelligence | Humanexa

Evidence Sources

Source-backed references used to construct this page.

FDA AP — DILTIAZEM HYDROCHLORIDE (SUPPL)
FDA
FDA document
View source
FDA AP — LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (SUPPL)
FDA
FDA document
View source
FDA AP — LURASIDONE HYDROCHLORIDE (SUPPL)
FDA
FDA document
View source
FDA AP — MILNACIPRAN HYDROCHLORIDE (SUPPL)
FDA
FDA document
View source
FDA AP — MILNACIPRAN HYDROCHLORIDE (SUPPL)
FDA
FDA document
View source
FDA AP — ONDANSETRON HYDROCHLORIDE (SUPPL)
FDA
FDA document
View source
Bacterial Profile Changes During Different Sodium Hypochlorite Irrigation Regimens and Calcium Hydroxide Medicament in Root Canal Treatment
ClinicalTrials.gov
FDA document
View source
Evaluating New Radiation Techniques for Cardiovascular Imaging
ClinicalTrials.gov
FDA document
View source
Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations
ClinicalTrials.gov
FDA document
View source
Rehabilitation Assessment of Motor Function In Cerebral Palsy Using Explainable AI
ClinicalTrials.gov
FDA document
View source
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patient
Merck
FDA document
View source
Effects of different caffeine doses on fat oxidation and cardiovascular response during exercise at FATmax in overweight/obese female college students.
PubMed
FDA document
View source
Effects of acute HMB-FA supplementation on antioxidant status and muscle damage in Elite Judoka: a randomized pilot trial.
PubMed
FDA document
View source
Immune correlates analysis in NextCOVE trial for a next-generation mRNA-1283 COVID-19 vaccine.
PubMed
FDA document
View source
Subacromial bursitis: current evidence and future directions in injection-based therapies-A narrative review.
PubMed
FDA document
View source
Microneedle-based injection of Fungizone/Amphotericin B: an effective treatment for American cutaneous leishmaniasis in mice.
PubMed
FDA document
View source
Safety and efficacy of ashwagen (a standardized withania somnifera extract) in stress and anxiety with hypertension and associated cardiometabolic risk factors: a randomized, placebo-controlled trial.
PubMed
FDA document
View source
FDA Grants AP Status for Diltiazem Hydrochloride ANDA216327
FDA
FDA document
View source
FDA Approval Status Update for Losartan Potassium by Micro Labs
FDA
FDA document
View source
FDA AP — LOSARTAN POTASSIUM (SUPPL)
FDA
FDA document
View source

Diltiazem Hydrochloride

Asset Overview

Company Context

Regulatory Timeline

FDA Grants Approval for Phenylephrine Hydrochloride by Baxter Healthcare

FDA Approval Status Update for Losartan Potassium by Micro Labs

FDA Grants AP Status for Diltiazem Hydrochloride ANDA216327

Related Signals

Evidence Sources